SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
暂无分享,去创建一个
A. Jankowska | C. O'keefe | J. Maciejewski | A. Jerez | M. Sekeres | H. Makishima | F. Traina | H. Rogers | V. Visconte | R. Tiu | H. Szpurka | H. J. Rogers | Fabiola Traina
[1] C. Will,et al. Spliceosome structure and function. , 2011, Cold Spring Harbor perspectives in biology.
[2] M. Cazzola,et al. Ring sideroblasts and sideroblastic anemias , 2011, Haematologica.
[3] Li Ding,et al. Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML. , 2011, JAMA.
[4] J. Licht,et al. DNMT3A mutations in acute myeloid leukemia , 2011, Nature Genetics.
[5] Li Ding,et al. Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes , 2011, Leukemia.
[6] T. Barbui,et al. JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations , 2011, Leukemia.
[7] R. Porcher,et al. The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation , 2010, Leukemia.
[8] Martin Dugas,et al. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] B. Dörken,et al. Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype , 2010, International journal of hematology.
[10] T. Cooper,et al. The pathobiology of splicing , 2010, The Journal of pathology.
[11] B. Storer,et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. , 2009, Blood.
[12] M. Fleming,et al. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia , 2009, Nature Genetics.
[13] D. Blaise,et al. Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison , 2009, Leukemia.
[14] J. Witte,et al. New classification of chronic GVHD: added clarity from the consensus diagnoses , 2009, Bone Marrow Transplantation.
[15] J. Sierra,et al. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] U. Germing,et al. High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable. , 2007, Blood.
[17] J. Maciejewski,et al. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation. , 2006, Blood.
[18] B. Quesnel,et al. High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis , 2006, Leukemia.
[19] M. Boissinot,et al. The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS). , 2006, Blood.
[20] B. Woda,et al. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features , 2006, Leukemia.
[21] J. Esteve,et al. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) , 2005, Leukemia.
[22] M. Cazzola,et al. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes. , 2005, Blood.
[23] M. Maris,et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. , 2003, Blood.
[24] B. Delaloye,et al. [Refractory anemia with "ring-sideroblasts" and alcoholism]. , 1971, Schweizerische medizinische Wochenschrift.